Search research articles
Contact Us
Filters
Showing results (31-40 of 130) with videos related to
Page
of 13
Sort By:
Journal of Neuro-Oncology
|
January 25, 2008
Hypertrophic olivary degeneration after resection of a cerebellar tumor
Serra Akar, Jan Drappatz, Liangge Hsu, et al.
Journal of Neuro-Oncology
|
July 29, 2023
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme
Megan Mantica, Jan Drappatz, Frank Lieberman, et al.
Journal of Neuro-Oncology
|
September 15, 2010
Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis
Laura L Horky, Edward M Hsiao, Stephanie E Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia
Santosh Kesari, Serra Akar, Ali Saad, et al.
Journal of Neuro-Oncology
|
August 4, 2010
Unexpected late radiation neurotoxicity following bevacizumab use: a case series
Paul J Kelly, Marc J Dinkin, Jan Drappatz, et al.
Leukemia & Lymphoma
|
April 28, 2016
Response of relapsed central nervous system hairy cell leukemia to vemurafenib
Michael M McDowell, Xiao Zhu, Nitin Agarwal, et al.
Journal of Neuro-Oncology
|
March 28, 2008
Prognostic factors in adult brainstem gliomas: a multicenter, retrospective analysis of 101 cases
Santosh Kesari, Ryung S Kim, Vassilios Markos, et al.
Tomography (Ann Arbor, Mich.)
|
July 26, 2018
[<sup>18</sup>F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment
Matthew J Oborski, Charles M Laymon, Frank S Lieberman, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
July 9, 2026
Clinical outcomes after transition from weight-based to fixed-dose glucarpidase for high-dose methotrexate toxicity at a large academic medical center
Melissa L Bastacky, Mario Martinez, Shrina Duggal, et al.
Brain and Behavior
|
April 1, 2014
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy
Matthew J Oborski, Charles M Laymon, Frank S Lieberman, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 130) with videos related to
Sort By:
Page
of 13
Journal of Neuro-Oncology
|
January 25, 2008
Hypertrophic olivary degeneration after resection of a cerebellar tumor
Serra Akar, Jan Drappatz, Liangge Hsu, et al.
Journal of Neuro-Oncology
|
July 29, 2023
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme
Megan Mantica, Jan Drappatz, Frank Lieberman, et al.
Journal of Neuro-Oncology
|
September 15, 2010
Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis
Laura L Horky, Edward M Hsiao, Stephanie E Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia
Santosh Kesari, Serra Akar, Ali Saad, et al.
Journal of Neuro-Oncology
|
August 4, 2010
Unexpected late radiation neurotoxicity following bevacizumab use: a case series
Paul J Kelly, Marc J Dinkin, Jan Drappatz, et al.
Leukemia & Lymphoma
|
April 28, 2016
Response of relapsed central nervous system hairy cell leukemia to vemurafenib
Michael M McDowell, Xiao Zhu, Nitin Agarwal, et al.
Journal of Neuro-Oncology
|
March 28, 2008
Prognostic factors in adult brainstem gliomas: a multicenter, retrospective analysis of 101 cases
Santosh Kesari, Ryung S Kim, Vassilios Markos, et al.
Tomography (Ann Arbor, Mich.)
|
July 26, 2018
[<sup>18</sup>F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment
Matthew J Oborski, Charles M Laymon, Frank S Lieberman, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
July 9, 2026
Clinical outcomes after transition from weight-based to fixed-dose glucarpidase for high-dose methotrexate toxicity at a large academic medical center
Melissa L Bastacky, Mario Martinez, Shrina Duggal, et al.
Brain and Behavior
|
April 1, 2014
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy
Matthew J Oborski, Charles M Laymon, Frank S Lieberman, et al.
Page
of 13